J. Moreb et al., OVEREXPRESSION OF THE HUMAN ALDEHYDE DEHYDROGENASE CLASS-I RESULTS ININCREASED RESISTANCE TO 4-HYDROPEROXYCYCLOPHOSPHAMIDE, Cancer gene therapy, 3(1), 1996, pp. 24-30
A correlation between overexpression of aldehyde dehydrogenase and res
istance to oxazaphosphorines, widely used anticancer agents, has been
shown. To investigate the direct role of the human aldehyde dehydrogen
ase class 1 (ALDH-1) in the resistance to one of these agents, 4-hydro
peroxycyclophosphamide (4-HC), an active metabolite of cyclophosphamid
e, neomycin-selectable plasmid or retroviral constructs harboring the
wild-type ALDH-1 complementary DNA in the sense orientation were trans
fected into K562 leukemic cell lines. Polymerase chain reaction (PCR)
analysis confirmed the presence of vector DNA in the stably transfecte
d K562 cells. Reverse transcriptase PCR and Northern and Western blot
analysis showed expression of ALDH-1 mRNA and protein in the cells tra
nsfected with ALDH-1 in the sense orientation but not in cells transfe
cted with vector alone. The activity of the expressed ALDH-1 was demon
strated using spectrophotometric assay. Stably transfected K562 cells
were subjected to various doses of 4-HC, and cell viability was assaye
d using clonogenic cell culture in semisolid medium. Results demonstra
te that K562 cells transfected with ALDH-1 in the sense orientation di
splay increased resistance to 4-HC compared with wild-type or vector-t
ransfected K562 cells. Furthermore, the addition of diethylaminobenzal
dehyde, a specific inhibitor for ALDH-1, restored the sensitivity of t
he ALDH-l-expressing K562 cells to 4-HC. Thus, the data pinpoint the d
irect role of ALDH-1 in the protection against 4-HC cytotoxicity.